Factors Related with Hospital Attendance and Mortality in Patients with COPD: A Case-Control Study in a Real-Life Setting

被引:7
作者
Estrella Lopez-Pardo, Maria [1 ]
Candal-Pedreira, Cristina [2 ]
Valdes-Cuadrado, Luis [3 ]
Represas-Represas, Cristina [4 ]
Ruano-Ravina, Alberto [2 ,5 ,6 ]
Perez-Rios, Monica [2 ,5 ,6 ]
机构
[1] Galician Hlth Serv, Dept Planning & Hlth Reform, Santiago De Compostela, Spain
[2] Univ Santiago de Compostela, Sch Med, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain
[3] Univ Clin Teaching Hosp Santiago de Compostela, Dept Pulm, Santiago De Compostela, Spain
[4] Alvaro Cunqueiro Univ Teaching Hosp, Resp Med, Vigo, Spain
[5] CIBERESP, CIBER Epidemiol & Salud Publ, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
[6] Hlth Res Inst Santiago de Compostela, Inst Invest Sanit Santiago de Compostela, IDIS, Santiago De Compostela, Spain
关键词
case-control study; COPD; hospital discharge; mortality; BURDEN;
D O I
10.2147/COPD.S355236
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: The rising trend in hospital admissions among patients with chronic obstructive pulmonary disease (COPD) is worrying, not only because of the increasing costs, but also because of the worsening quality of life. We aimed to identify the predictive factors of hospital admission, re-admission and mortality of COPD patients through using information exclusively registered in electronic clinical records. Methods: We conducted a population-based case-control study. All data were sourced from the different information systems comprising the Galician Health Service electronic record database. We included in the study patients diagnosed with COPD (code R95 in the medical record), >= 35 years old and with at least one spirometry performed =3 years prior inclusion. We fitted three logistic regression models, each one to ascertain the factors that influence the probability of admission, re-admission, and mortality, and calculated odds ratios (OR) with their 95% confidence intervals (95% CI). Results: COPD patients were admitted due to respiratory causes a mean of 1.51 times across the period December 2016-December 2017, with 55% requiring re-admission in the next 90 days. The factor most closely associated with the re-admission profile was home oxygen therapy (OR 3.06 95% CI 2.42-3.87), followed by male gender (OR 2.01 95% CI 1.48-2.72), a CHA2DVASc scale score >2 (OR 1.28 95% CI 1.16-1.42), and severity by clinical risk group stratification (OR 1.14 95% CI 1.04-1.26). Male sex (OR 1.47 CI 95% 1.04-2.09), having been readmitted =2 times (OR 1.34 CI 95% 1.11-1.61) and being =70 years old (OR 1.05 CI 95% 1.03-1.08) increase the probability of dying from COPD during the study period. Conclusion: These results confirm the complexity of management of COPD exacerbations, and indicate the need to establish strategies that would ensure continuity of care after hospital admission, with the aim of preventing re-admissions and death.
引用
收藏
页码:809 / 819
页数:11
相关论文
共 28 条
[1]   Comorbidome and short-term prognosis in hospitalised COPD patients: the ESMI study [J].
Almagro, Pere ;
Javier Cabrera, Francisco ;
Diez-Manglano, Jesus ;
Boixeda, Ramon ;
Recio, Jesus ;
Mercade, Joan ;
Yun, Sergi ;
Soriano, Joan B. .
EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (03) :850-853
[2]  
Ancochea J, 2010, Spanish National Health System COPD strategy
[3]   Exacerbations of chronic obstructive pulmonary disease: time to rename [J].
Bafadhel, Mona ;
Collis, Philip ;
Criner, Gerard ;
Dransfield, Mark T. ;
Janssens, Wim ;
McDonald, Vanessa M. ;
Vogelmeier, Claus F. ;
Russell, Richard E. K. .
LANCET RESPIRATORY MEDICINE, 2020, 8 (02) :133-135
[4]   Hospital Readmissions for COPD: We Can Meet the Challenge [J].
Braman, Sidney S. .
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2015, 2 (01) :4-7
[5]   An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease [J].
Celli, Bartolome R. ;
Decramer, Marc ;
Wedzicha, Jadwiga A. ;
Wilson, Kevin C. ;
Agusti, Alvar ;
Griner, Gerard J. ;
MacNee, William ;
Make, Barry J. ;
Rennard, Stephen I. ;
Stockley, Robert A. ;
Vogelmeier, Claus ;
Anzueto, Antonio ;
Au, David H. ;
Barnes, Peter J. ;
Burgel, Pierre-Regis ;
Calverley, Peter M. ;
Casanova, Ciro ;
Clini, Enrico M. ;
Cooper, Christopher B. ;
Coxson, Harvey O. ;
Dusser, Daniel J. ;
Fabbri, Leonardo M. ;
Fahy, Bonnie ;
Ferguson, Gary T. ;
Fisher, Andrew ;
Fletcher, Monica J. ;
Hayot, Maurice ;
Hurst, John R. ;
Jones, Paul W. ;
Mahler, Donald A. ;
Maltais, Francois ;
Mannino, David M. ;
Martinez, Fernando J. ;
Miravitlles, Marc ;
Meek, Paula M. ;
Papi, Alberto ;
Rabe, Klaus F. ;
Roche, Nicolas ;
Sciurba, Frank C. ;
Sethi, Sanjay ;
Siafakas, Nikos ;
Sin, Don D. ;
Soriano, Joan B. ;
Stoller, James K. ;
Tashkin, Donald P. ;
Troosters, Thierry ;
Verleden, Geert M. ;
Verschakelen, Johny ;
Vestbo, Jorgen ;
Walsh, John W. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (07) :831-844
[6]  
Cerezo Lajas A, 2018, Rev patol respir, V21, P79
[7]   Clinical audit of patients hospitalized due to COPD exacerbation. MAG-1 Study [J].
Escarrabill, Joan ;
Torrente, Elena ;
Esquinas, Cristina ;
Hernandez, Carme ;
Monso, Eduard ;
Freixas, Montserrat ;
Almagro, Pere ;
Tresserras, Ricard .
ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (10) :483-489
[8]   Social Profile of Patients Admitted for COPD Exacerbations. A Gender Analysis [J].
Fernandez-Garcia, Sara ;
Represas-Represas, Cristina ;
Ruano-Ravina, Alberto ;
Mosteiro-Anon, Mar ;
Mouronte-Roibas, Cecilia ;
Fernandez-Villar, Alberto .
ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (02) :84-89
[9]   The impact of integrated disease management in high-risk COPD patients in primary care [J].
Ferrone, Madonna ;
Masciantonio, Marcello G. ;
Malus, Natalie ;
Stitt, Larry ;
O'Callahan, Tim ;
Roberts, Zofe ;
Johnson, Laura ;
Samson, Jim ;
Durocher, Lisa ;
Ferrari, Mark ;
Reilly, Margo ;
Griffiths, Kelly ;
Licskai, Christopher J. ;
Atkins, Andrew ;
Baker, Bill ;
Dalo, Sara ;
Piccinato, Jean ;
Waddick, Denise ;
Wong, Brice .
NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2019, 29 (1)
[10]  
Fuertes Goni MC, 2017, Med Gen, V6, P3